Dover has entered into a definitive agreement to accumulate Malema Engineering Corp, a US designer and producer of high-precision, mission-critical flow-measurement and control devices for the biopharmaceutical, semiconductor and industrial sectors.
ส่วนประกอบpressuregauge will increase Dover’s biopharma single-use manufacturing offering, which already consists of Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with amenities in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in revenue during the full yr 2022.
When the deal closes, Malema will turn out to be a part of the PSG business unit inside Dover’s Pumps & Process Solutions segment.
“We see an incredible long-term progress opportunity in the bioprocessing business driven by a powerful and growing pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more environment friendly single-use production processes helps a robust outlook for our offerings of single-use components to end-customers. We imagine that pairing Malema’s technology with our current portfolio of single-use pumps for biopharma processing will significantly improve the accuracy and value proposition of our solutions to our customers.”
“We are methodically constructing out our biopharma platform via proactive capability additions, new product improvement, and opportunistic acquisitions of highly-attractive niche element technologies,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing know-how and additional strengthens our sensor portfolio with new proprietary know-how. In addition to attractive biopharma applications, we anticipate sturdy development within the semiconductor space on the capacity growth and re-shoring tailwinds.”
Share